[ RadSafe ] " House Committee Passes Bill to Create US IsotopeSupply "

[Edmond Baratta]

One wonders how they are going to produce the Mo-99 from an without the use 
of enriched uranium?   The earlier method was from neutron actived Mo, which 
resulted in a lot of waste.  Where are they going to find a Reactor to 
produce it.  It appears that the House in its usual short sightedness has 
struck again.

Ed Baratta

edmond0033 at comcast.net

--------------------------------------------------
From: "Franta, Jaroslav" <frantaj at aecl.ca>
Sent: Monday, October 26, 2009 12:05 PM
To: "Radsafe (E-mail)" <radsafe at radlab.nl>
Subject: [ RadSafe ] " House Committee Passes Bill to Create US 
IsotopeSupply "

> UNRESTRICTED | ILLIMITÉ
>
> Gee.....  one wonders why they didn't simply keep FFTF in operation - 
> retasked to meds production ??
>
> Jaro
> ^^^^^^^^^^^^^^^^^^^^
>
>
> House Committee Passes Bill to Create US Isotope Supply
> Device & Diagnostic Letter
> Vol. 36, No. 42
> 26 October 2009
>
> To head off future shortages of the most commonly used diagnostic 
> radioisotope, a House committee has passed a bill to create a steady 
> domestic supply of molybdenum-99 (Mo-99).
>
> The American Medical Isotopes Production Act, H.R. 3276, gives the Energy 
> Department the authority and funding to help the private sector establish 
> a U.S. supply of Mo-99 without using highly enriched uranium, according to 
> a statement from the House Energy and Commerce Committee.
> <SNIP>
>
> <SNIP>
> If passed, the House bill could help advance two private projects already 
> in the works, Matmuller said, as it includes a $163 million provision to 
> support domestic production of the isotope (D&DL, Sept. 14).
>
> In February, Covidien signed an agreement with Babcock & Wilcox to develop 
> technology to manufacture Mo-99 in the U.S. When complete, the 
> collaboration could supply more than 50 percent of the U.S. demand for the 
> radioisotope (D&DL, Feb. 2). Last year, Advanced Medical Isotope signed an 
> agreement with the University of Missouri Research Reactor Center to 
> develop the isotope.
>
> Neither of these projects has applied to formally begin the regulatory 
> approval process, Robert Lewis, director of NRC's Division of Materials 
> Safety and State Agreements, said.
>
> In related news, the NRC also has noticed a shortage of another prominent 
> medical isotope, iodine-131, Matmuller said.
> <SNIP>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
>
> CONFIDENTIAL AND PRIVILEGED INFORMATION NOTICE
>
> This e-mail, and any attachments, may contain information that
> is confidential, subject to copyright, or exempt from disclosure.
> Any unauthorized review, disclosure, retransmission,
> dissemination or other use of or reliance on this information
> may be unlawful and is strictly prohibited.
>
> AVIS D'INFORMATION CONFIDENTIELLE ET PRIVILÉGIÉE
>
> Le présent courriel, et toute pièce jointe, peut contenir de
> l'information qui est confidentielle, régie par les droits
> d'auteur, ou interdite de divulgation. Tout examen,
> divulgation, retransmission, diffusion ou autres utilisations
> non autorisées de l'information ou dépendance non autorisée
> envers celle-ci peut être illégale et est strictement interdite.
>
> _______________________________________________
> You are currently subscribed to the RadSafe mailing list
>
> Before posting a message to RadSafe be sure to have read and understood 
> the RadSafe rules. These can be found at: 
> http://radlab.nl/radsafe/radsaferules.html
>
> For information on how to subscribe or unsubscribe and other settings 
> visit: http://radlab.nl/radsafe/
>